News
Tempus AI, Bristol Myers Squibb Expand AI-Driven Clinical Trial Efforts
1+ hour, 14+ min ago (321+ words) Tempus AI Inc. announced a new collaboration initiative with Bristol Myers Squibb Co. aimed at improving clinical trial design and increasing the Probability of Technical & Regulatory Success across five initial development programs. The companies plan to use artificial intelligence, multimodal…...
Antibiotics Ineffective for Wheezing Episodes in Young Children in
4+ hour, 36+ min ago (928+ words) A recent large-scale clinical trial led by researchers at the University of Arizona's College of Medicine " Tucson has delivered a definitive verdict on the efficacy of azithromycin in treating severe wheezing episodes in preschool children. The study rigorously tested the…...
Antibiotic proves ineffective in treating wheezing in young children in the emergency room
15+ hour, 46+ min ago (29+ words) Research and Partnerships Antibiotic proves ineffective in treating wheezing in young children in the emergency room...
Breakthrough Molecular Marker Promises Enhanced Prostate Cancer Therapy
6+ hour, 18+ min ago (907+ words) Bioengineer. org Breakthrough Molecular Marker Promises Enhanced Prostate Cancer Therapy Prostate cancer remains one of the most prevalent malignancies affecting men worldwide, and its treatment landscape is continually evolving. Central to the growth and survival of the majority of prostate…...
Tri Cel X Files FDA IND for Xytri X" in Chronic Traumatic Encephalopathy (CTE)
16+ hour, 10+ min ago (238+ words) Xytri X" Becomes First CTE Biotherapeutic to Reach FDA Under the Blast Overpressure Safety Act This is the first IND filing for a CTE-directed biotherapeutic since the enactment of the Blast Overpressure Safety Act (BOSA) in December 2024. Xytri X" is…...
New pancreatic cancer pill could reshape treatment as early trial results stun researchers
16+ hour, 45+ min ago (848+ words) A new drug for pancreatic cancer is showing promise in early testing. Daraxonrasib is a daily pill designed to block cancer signals linked to the RAS gene. It has now finished an early-stage clinical trial " the first time it was…...
Parexel Launches Parexel AI Suite of Human-Led AI Services for Clinical Trials
13+ hour, 23+ min ago (143+ words) What You Should Know Peyton Howell, Chief Executive Officer of Parexel, stated that Parexel AI represents years of deep technology integration aimed at helping sponsors run faster, more effective trials. The platform relies on a mix of internal innovation and…...
Re Engage Therapeutics Expands Sponsored Research Agreement to Develop ACSS2 Inhibitors for Chemorefractory Cancers
12+ hour, 22+ min ago (219+ words) Weekly Voice The Largest South Asian News Platforms since 1997 Expansion adds Co-Principal investigator that Broadens Collaboration into Ovarian and Urologic Cancers HOUSTON, TX, UNITED STATES, May 18, 2026 /EINPresswire. com/ " Re Engage Therapeutics, a clinical-stage pharmaceutical company combatting cancer by reversing chemotherapy…...
Emory physicians work to expand access to clinical trials at community hospitals
9+ hour, 34+ min ago (458+ words) May 18, 2026 2: 11 PM LISTEN: Access to clinical trials that test new medications or treatments'is often limited to patients at major academic hospitals. GPB's Sofi Gratas has more about efforts to address the problem. That's one barrier for patients, according to Larry…...
Apnimed’s sleep apnea pill meets main goal in late-stage study | WIN 98. 5 Your Country | WNWN-FM | Battle Creek, MI
13+ hour, 33+ min ago (40+ words) May 18 (Reuters) - Privately held biotech firm Apnimed said on Monday its experimental pill for a sleep disorder met the main goal in a late-stage trial, "potentially offering a convenient alternative to device-based treatments. Here are the details: .. ....